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Summary. The effects of guanidine on motoneurons 
of the isolated frog spinal cord were studied by adding 
the drug to the solution bathing the cord during intra- 
cellular recording. Guanidine (5.10 -4 M) did not 
alter the membrane potential of motoneurons. 
The main effect was a marked increase of the ampli- 
tudes and frequencies ofsmall spontaneously occurring 
inhibitory postsynaptic potentials. The hyperpolariz- 
ing component of postsynaptic potentials evoked by 
stimulation of dorsal roots was also enhanced by 
guanidine. Higher concentrations of guanidine (5 
9 10 -3 M) resulted in a very large and irreversible in- 
crease of the small spontaneously occurring inhibitory 
potentials, which now appeared in a regular, rhythmic 
pattern. 
The effects of guanidine could easily be blocked 
by increasing the magnesium ions (15 raM) in the bath 
solution. 
These results indicate that guanidine facilitates the 
release of an inhibitory transmitter in afferent ter- 
minals of the frog spinal cord either by a direct action 
on these terminals or indirectly by an action on nerve 
endings impinging on inhibitory interneurons. 
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fibrillary twitches of muscles combined with tonic 
extensor spasms of the extremities. They concluded 
that guanidine had 2 sites of action: one the neuro- 
muscular junction and another the spinal cord. The 
action of guanidine on neuromuscular t ansmission 
was investigated in detail (Otsuka and Endo, 1960; 
Kamenskaya et al., 1975 a, b; Terfivfiinen and Larsen, 
1975) and has led to the clinical use of this drug in 
the treatment of botulism (Scaer et al., 1969; Ricker 
and D611, 1970), and of the myasthenic syndrome 
(Lambert and Elmquist, 1971; Oh and Kim, 1973). 
Only very little, however, is known about the 
effects of guanidine within the spinal cord (Koizumi, 
1955). Based upon empirical data guanidine was 
proposed for the treatment of patients uffering from 
amyotrophic lateral sclerosis (Norris et al., 1974); 
its effectiveness was, however, not confirmed by Wie- 
derholt (1975). Therefore, it seemed necessary to ob- 
tain more experimental results on the action of guani- 
dine on synaptic transmission i spinal cord. For this 
purpose we used the isolated spinal cord of the frog. 
This preparation offers many advantages for pharma- 
cological investigations (Sonnhof et al., 1975). In the 
present paper we report on the effects of guanidine on 
the membrane potential and on postsynaptic potentials 
of motoneurons. 
INTRODUCTION 
As early as 1876 the effects of guanidine on the motor 
system of frogs were described by Gergens and Bau- 
mann to consist of 2 phenomena: the induction of 
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METHODS 
Experiments were performed on the frog, Rana esculenta, using a 
method described by Sonnhof et al. (1975). After decapitation a 
ventral laminectomy was performed in cooled Ringer solution. The 
spinal cord, including dorsal and ventral roots of the lumbar seg- 
ments, was removed and placed in a recording chamber consisting 
of a perspex block with a small groove (volume 1.5 ml), which was 
continuously superfused with Ringer solution by means of a roller 
pump (2 ml/min). The Ringer solution contained (in raM): NaCI 
108.0, KC13.65, NaHCO3 12.0, CaCI2 1.5 and additionally Dextrose 
2 g/1. The temperature of the perfusion fluid was adjusted to 22~ 
by a Peltier element. Ventral and dorsal roots of the lumbar segments 
of one side were placed on silver wire electrodes for stimulation and 
130 Naunyn-Schmiedeberg's Arch. Pharmacol, 301 (1977) 
covered with a mixture of paraffin and vaseline. Ringer solutions 
containing guanidine (guanidinium chloride, Merck) and high 
magnesium concentrations were stored in vessels which could be 
connected to the chamber during intracellular recording from moto- 
neurons. All solutions were gassed with a mixture of 02 and CO2 
and were pH-stabilized at 7.4 with Tris-(hydroxymethyl)-methyl-2- 
aminoethane-sulfonic acid. For insertion of microelectrodes the 
spinal meninges between ventral and dorsal roots were carefully 
removed. Recording electrodes (tip diameter below 1 ~tm) were 
filled with potassium acetate (3M). Stable intracellular records from 
motoneurons could frequently be achieved for several hours. The 
membrane potential was monitored continuously by a compensa- 
tion writer and quick signals were displayed on oscilloscopes and 
recorded as photographs. 
RESULTS 
Successful intracellular records were obtained in 46 
lumbar motoneurons of 17 isolated frog spinal cord 
preparations. Concentrations of guanidine in the bath 
solution from 10 -4 to 5 9 10 .3 M were used and the 
duration of exposure varied between 3 and 15 min. 
A detailed investigation was performed with a con- 
centration of 5 9 10 .4 M, because the effects of guani- 
dine in this concentration were reversible. High con- 
centrations (5. 10-3), however, caused irreversible 
changes of synaptic activity. 
Effects of Guanidine in Low Concentration (5 9 10-4 M) 
The main effect of guanidine was a marked increase in 
the amplitude and the frequency of the small, sponta- 
neously occurring postsynaptic potentials. In Figure 1 
a typical example for this action of guanidine is 
presented. In Figure 1 A the resting membrane poten- 
tial and the postsynaptic potentials (PSP) evoked by 
dorsal root (DR) stimulation (DR-PSP) of a moto- 
neuron were recorded with a compensation writer. 
In addition, as shown in Figure 1 B the resting mem- 
brane potential is demonstrated with high speed and 
amplification from an oscilloscope. As can be seen in 
Figure 1 B1 also under normal conditions the mem- 
brane potential showed small irregular appearing 
oscillations. These small postsynaptic potentials of 
frog motoneurons were first described by Katz and 
Miledi (1963) and were called "spontaneous miniature 
potentials". Some minutes after the application of 
guanidine into he bath solution (5 9 10 .4 M/7 min) 
these potentials trongly increased in amplitude and 
frequency (Fig. 1 B3). The membrane potential, how- 
ever, was not changed. The effect of guanidine was 
reversible. About 20 rain after the end of application 
all intracellular measurable signals reached their con- 
trol values. 
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Fig. 1 A and B. Effect ofguanidine inlow concentration (5 - 10-4 M). (A) lntracellular recording from a motoneuron. Postsynaptic potentials 
were induced by stimulation of a dorsal root (DR-PSP). Guanidine (5.10-4 M) was present in the bath solution for 7 min (indicated by the 
horizontal bar below the record, transport time in the tube system was 2 min). At the times indicated by the Figures 1 - 5, stimulation of the 
dorsal root was stopped. (B) Tracings recorded at higher sweep speed and corresponding to the times indicated by the Figures 1 -  5 in A. 
Continuous registration from top to bottom. Note, at this high amplification the small spontaneous postsynaptic potentials, which were 
markedly increased in amplitude and frequency by guanidine 
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Fig.2A and B 
Changes of postsynaptic potentials (DR-PSP) during 
intracellular current injection. In A postsynaptic 
potentials induced by dorsal root stimulation (DR- 
PSP) and the membrane potential were recorded with 
the compensation writer during intracellular current 
injections. In B corresponding DR-PSPs are photo- 
graphed from the oscilloscope. Only depolarizing 
PSPs are recorded without current injection (0 nA) in 
frog motoneurons. When the membrane potential, 
however, was decreased by intracellular current in- 
jections (6 nA dep.) it was possible to differentiate 
between depolarizing and hyperpolarizing components 
of the evoked PSPs 
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Effect of guanidine in low concentra- 
tion (5 9 10 .4 M) during intracellular 
current injection. The membrane 
potential of this motoneuron was 
depolarized by intracellular current 
injection (5 nA) of sufficient strength 
for the appearance ofhyperpolarizing 
inhibitory components of the DR-PSP 
(see Figs.2B, 3C). (A and B) Same 
registration as in Figure 1. In part B~ 
small spontaneous depolarizing 
EPSPs and hyperpolarizing IPSPs 
are visible. Note, that only the sponta- C ' 
neous IPSPs are increased by guani- 
dine (B2). (C) Before each period - - / - -~  
i - 3 one stimulus induced post- 
synaptic potential (DR-PSP) was 
photographed from the oscilloscope. 
C, a represents he DR-EPSP and 
C, b, c mark the two parts of the DR- 
IPSPs. (D) The DR-PSP before 
(upper trace) and during (lower 
trace) the action of guanidine are 
photographically superimposed. Note 
the increase in amplitude and the 
shortening of the latency ofthe first 
part (b) of the DR-IPSP 
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The postsynaptic potentials evoked or increased 
by guanidine were usually depolarizing ones. In spite 
of this they have to be considered as inhibitory post- 
synaptic potentials (IPSP) for reasons demonstrated 
in Figures 2 and 3. In spinal motoneurons of the frog 
it is a common feature, that only depolarizing PSPs are 
recordable (Katz and Miledi, 1963). However, a 
depolarization of the membrane potential by intra- 
cellular current injection reverses one component of 
the PSP into a hyperpolarizing direction, thus charac- 
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terizing it as an IPSP (Fig.2; Sonnhof et al., 1975). 
Therefore in Figure 3 the effect of guanidine was ana- 
lyzed during constant depolarization of a motoneu- 
ton by intracellular depolarizing current injections. 
Under such conditions it was possible to differ- 
entiate between spontaneous depolarizing excitatory 
postsynaptic potentials (EPSPs) and hyperpolarizing 
IPSPs (Fig. 3 B1). Guanidine (5 9 10-4) in the bath solu- 
tion selectively increased the amplitude and frequency 
of the small hyperpolarizing IPSPs (Fig. 3B2)-the 
depolarizing EPSPs remained unchanged. 
In Figure 3 C, D the action ofguanidine upon post- 
synaptic potentials following stimulation of the dorsal 
roots (DR-PSP) is demonstrated. These DR-PSPs 
consisted of an initial depolarizing component of 
small amplitude (DR-EPSP; Fig. 3 C, a) and a subse- 
quent longer lasting hyperpolarizing potential of 2 
different portions (DR-IPSPs; Fig.3C, b, c). These 
two hyperpolarizing potentials are well defined as 
IPSPs, since they have a reversal potential near the 
resting membrane potential and are accompanied by 
a strong increase in membrane conductance (not 
demonstrated). During guanidine application the 
amplitude and the steepness ofthe early IPSP (Fig. 3 C, 
D) increased in correspondence with the enhancement 
of the spontaneously occurring inhibitory potentials. 
The reversal potential of the IPSPs remained unchang- 
ed. The amplitude of the early DR-IPSP reversibly 
decreased about 30 min after guanidine application 
ended (Fig. 3C, 1 -  3). Additionally a shortening of 
the latency of the DR-IPSP was observed. The small 
depolarizing EPSP (Fig. 3C, a), however, remained 
unchanged. 
Effects of Guanidine during High Magnesium 
Concentration 
Synaptic transmission i  the frog spinal cord is blocked 
by adding magnesium ions to the bath solution (Erul- 
kar et al., 1974; Sonnhof et al., 1977). Under such an 
experimental condition the action of guanidine was 
completely abolished. This is illustrated in Figure 4, 
which shows a continued intracellular recording from 
the same motoneuron asshown in Figure 1. The spinal 
cord now was superfused with Ringer solution, in 
which an equimolar amount of NaC1 was substituted 
by 15 mM MgCI2. About 5 min after the beginning 
of the superfusion the DR-PSP's were diminished 
(Fig.4A) and completely blocked after 9 rain. The 
membrane potential showed a small hyperpolarizing 
shift at the same time. After that time the effect of 
guanidine was completely blocked (Fig.4B). Only 
some very small postsynaptic potentials could be 
recorded also in the presence of magnesium ions 
(Fig.4B). These potentials may originate from a 
spontaneous transmitter rel ase in synaptic terminals, 
which cannot be blocked by magnesium (Katz and 
Miledi, 1963; Erulkar et al., 1974). 
Effects of Guanidine in Higher Concentration 
In contrast to the action of guanidine in a concentra- 
tion of 5 9 10 -4 M the application of guanidine in a 
concentration f 5 - 10 -3 M induced strong and very 
long lasting effects. As shown in Figure 5 A guanidine 
in this concentration very strongly increased theampli- 
tude and the frequency of the spontaneous post- 
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Fig.4A and B 
Effect of guanidine during high mag- 
nesium concentration. Recording from 
the same motoneuron as shown" in 
Figure 1. (A and B) Same registration as 
in Figure 1. During the period indicated 
by the upper bar normal Ringer solution 
was replaced by a solution containing 
MgC12 in a concentration f 15 mM. 
Note, that guanidine action under such 
conditions was blocked (application i - 
dicated by the lower bar) 
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Fig. 5A-C  
Effect of guanidine in high concentration 
(5 - 10 -3 M). (A) Intracellular registration of 
the membrane potential of a spinal moto- 
neuron. Guanidine in a concentration of
5 - 10- 3 M was applied into the Ringer 
solution, Note the strong fluctuations of the 
membrane potential induced by the increase 
of spontaneous postsynaptic potentials. (B) 
Registration of the membrane potential from 
the same motoneuron as in A with higher 
speed. (C) Registration of the membrane 
potential oscillations induced by guanidine 
in high concentration (5 - 10 .3 M) during 
intracellular current injection. The direction 
of the oscillations are reversed from a de- 
polarization into a hyperpolarization by
shifting the membrane potential from 
- 60 mV to - 50 mV by 7 nA depolarizing 
current strength. Vice versa the amplitude of
the depolarizing oscillations increased by a 
hyperpolarization f the membrane potential 
from - 60 mV to - 70 mV (5 nA current 
strength) 
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synaptic potentials. After a few minutes these large 
spontaneous postsynaptic potentials appeared in a 
rather regular, rhythmic pattern. By summation they 
produced periodic changes of the resting membrane 
potential of the motoneurons by about 5 to 10 mV 
revealing a rather regular frequency of 0.3-0.1 cps 
(Fig. 5 B). These waves of summed synaptic potentials 
were recorded as long as 3 -4  h. In Figure 5C these 
slow membrane potential oscillations are investigated 
by changing the membrane potential of the moto- 
neuron by intracellular current injection. The oscilla- 
tions are reversed from a depolarizing direction into 
a hyperpolarizing direction. On the other hand the 
amplitude of the spontaneous o cillation was increased 
when the membrane potential was increased by hyper- 
polarizing current injection. This indicates, that the 
regular oscillations of the membrane potential in- 
duced by guanidine are caused by summation of spon- 
taneous inhibitory postsynaptic potentials with a 
reversal potential similar to that of the stimulus 
induced DR-IPSP. All these guanidine effects were 
completely blocked within 5 min by adding mag- 
nesium ions (15 raM) into the bath solution. 
DISCUSSION 
Guanidine in our experiments increased the ampli- 
tude of inhibitory postsynaptic potentials in spinal 
motoneurons either occurring spontaneously or in- 
duced by stimulation of the dorsal roots. In contrast, 
EPSP's were uneffected. Extensive measurements on
the neuromuscular transmission have shown that 
guanidine increases the amount of transmitter mole- 
cules released from nerve endings (Otsuka and Endo, 
1960; Kamenskaya et al., 1975a, b; Ter/iv/iinen and 
Larsen, 1975). Our results indicate, hat in accordance 
with the observations of Koizumi (1955), guanidine 
acts in a similar way also upon the synaptic transmis- 
sion in the spinal cord. 
The increase in the amplitude of inhibitory post- 
synaptic potentials induced by dorsal root stimula- 
tion (DR-IPSP) in the spinal cord of the frog is com- 
parable with the enhancement in the amplitude of 
endplate potentials caused by guanidine in nerve- 
muscle preparations (Otsuka nd Endo, 1960; Kamen- 
skaya et al., 1975a, b; Terfivfiinen and Larsen, 1975). 
The small postsynaptic potentials in spinal moto- 
neurons of the frog originate from action potentials of 
spontaneously active interneurons and, similar to the 
miniature ndplate potentials of neuromuscular trans- 
mission, from a spontaneous transmitter release in 
the nerve terminals (Katz and Miledi, 1963; Colomo 
and Erulkar, 1968). Guanidine, however, only en- 
hanced the action potential induced transmitter r -
lease, since in contrast o the spontaneous transmitter 
release, which is resistant to high magnesium concen- 
trations (Katz and Miledi, 1963; Erulkar et al., 1974), 
stimulus induced synaptic activation, as well as the 
action of guanidine were blocked by addition of mag- 
nesium ions (15 mM) into the Ringer solution (see 
Fig. 4). This observation corresponds to the effect of 
guanidine on the neuromuscular synapse, where the 
miniature endplate potentials also remained unchang- 
ed (Kamenskaya et al., 1975a, b; Terfivfiinen and 
Larsen, 1975). Additionally Otsuka and Endo (1960) 
observed spontaneously appearing "giant potentials" 
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in guanidine treated nerve-muscle preparations. Based 
on this finding they proposed a transmitter release 
caused by a spontaneous excitation of presynaptic 
points by guanidine. The great increase in frequency 
of the small postsynaptic potentials in our experi- 
ments indicates, that such a spontaneous excitation of 
presynaptic terminals followed by a release of trans- 
mitter molecules beside the enhancement of action 
potential induced transmitter release is an important 
action of guanidine. 
The best explanation for our results seems to be an 
effect of guanidine on some specific presynaptic ter- 
minals. As demonstrated in Figure 3 guanidine en- 
hanced only inhibitory postsynaptic potentials. Also 
with high concentration the increase of spontaneous 
inhibitory potentials was the main effect of guanidine 
(see Fig. 5). But it remains unclear, whether guanidine 
facilitates the transmitter release by direct action on 
inhibitory afferent terminals or indirectly by an action 
on nerve endings impinging on inhibitory inter- 
neurons. To answer the question whether guanidine, 
like in the neuromuscular transmission, selectively 
acts on acetylcholine containing synaptic terminals 
more experimental work has to be done. The enhance- 
ment of acetylcholine release from axon collaterals of 
motoneurons is possible, the synaptic pathway, how- 
ever, of recurrent inhibition in frog spinal cord is not 
yet clear. A recurrent postsynaptic inhibition from 
Renshaw type is absent in frog spinal cord (for review 
see Simpson, 1976). 
It is difficult to explain the described therapeutic 
effect of guanidine in the treatment of amyotrophic 
lateral sclerosis (Norris et al., 1974). The main problem 
is the unknown etiology of the amyotrophic lateral 
sclerosis. But one possible effect of guanidine therapy 
may be, that a permanent activation of the post- 
synaptic membrane by small postsynaptic potentials 
may have a trophic effect upon motoneurons which 
counteracts the degenerative process of the disease. 
From clinical view beside such a assumed therapeutic 
effect the described side effects of guanidine, which 
may be serious (bone marrow depression), have to be 
considered (Norris et al., 1974; Wiederholt, 1975). 
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